...
首页> 外文期刊>Brain >Immunomodulatory effects of Vitamin D in multiple sclerosis
【24h】

Immunomodulatory effects of Vitamin D in multiple sclerosis

机译:维生素D在多发性硬化症中的免疫调节作用

获取原文
获取原文并翻译 | 示例

摘要

Although Vitamin D is best known as a modulator of calcium homeostasis, it also has immune modulating potential. A pro-ntective effect of Vitamin D on multiple sclerosis is supported by the reduced risk associated with sun exposure and use ofnVitamin D supplements. Moreover, high circulating levels of Vitamin D have been associated with lower risk of multiplensclerosis. In this study, we measured 1,25 (OH)2 Vitamin D and 25 (OH) Vitamin D levels in multiple sclerosis patientsnseparated into different clinical subgroups according to disease status. In addition, direct effects of 1,25 (OH)2 Vitamin D onnex vivo CD4+ T cells and myelin-peptide specific T cell lines were investigated to gain more insight into putative regulatorynmechanisms in the disease pathogenesis. One hundred and thirty-two Hispanic patients with clinically definite multiple sclerosisnwere studied, 58 with relapsing remitting multiple sclerosis during remission, 34 during relapse and 40 primary progressivenmultiple sclerosis cases. Sixty healthy individuals matched with respect to place of residence, race/ethnicity, age and gendernserved as controls. Levels of 25(OH)D3 and 1,25(OH)2D3, measured by ELISA were significantly lower in relapsing–remittingnpatients than in controls. In addition, levels in patients suffering relapse were lower than during remissions. In contrast, primarynprogressive patients showed similar values to controls. Proliferation of both freshly isolated CD4+ T cells and MBP-specificnT cells was significantly inhibited by 1,25(OH)2D3. Moreover, activated Vitamin D enhanced the development of IL-10 pro-nducing cells, and reduced the number of IL-6 and IL-17 secreting cells. Notably, Vitamin D receptor expression was inducednby 1,25(OH)2D3 in both activated and resting cells. Interestingly, T cells were able to metabolize 25(OH)D3 into biologicallynactive 1,25(OH)2D3, since T cells express a1-hydroxylase constitutively. Finally, 1,25(OH)2D3 also increased the expressionnand biological activity of indoleamine 2,3-dioxygenase, mediating significant increase in the number of CD4+CD25+ T regu-nlatory cells. Collectively, these data suggest that 1,25(OH)2D3 plays an important role in T cell homeostasis during the coursenof multiple sclerosis, thus making correction of its deficiency may be useful during treatment of the disease.
机译:尽管维生素D最著名的是钙稳态的调节剂,但它也具有免疫调节的潜力。维生素D对多发性硬化症的预防作用可通过减少与日晒和使用维生素D补充剂相关的风险得到支持。此外,维生素D的高循环水平与多发性硬化症的风险较低有关。在这项研究中,我们测量了根据疾病状况分为不同临床亚组的多发性硬化症患者中1,25(OH)2维生素D和25(OH)维生素D的水平。此外,还研究了1,25(OH)2维生素D onnex体内CD4 + T细胞和髓磷脂肽特异T细胞系的直接作用,以更深入地了解疾病发病机理中的假定调控机制。研究了132名具有临床定义的多发性硬化症的西班牙裔患者,58例缓解期复发缓解型多发性硬化症,34例复发期间和40例原发性进行性多发性硬化症患者。六十名健康的个体在居住地,种族/民族,年龄和性别方面相匹配,作为对照。 ELISA检测的复发-转诊患者的25(OH)D3和1,25(OH)2D3的水平明显低于对照组。另外,复发患者的水平低于缓解期间的水平。相反,原发进展型患者显示出与对照相似的值。 1,25(OH)2D3显着抑制了新鲜分离的CD4 + T细胞和MBP特异性T细胞的增殖。此外,活化的维生素D增强了IL-10生产细胞的发育,并减少了IL-6和IL-17分泌细胞的数量。值得注意的是,维生素D受体的表达是由1,25(OH)2D3在活化和静息细胞中诱导的。有趣的是,由于T细胞组成性表达α1-羟化酶,因此T细胞能够将25(OH)D3代谢为具有生物活性的1,25(OH)2D3。最后,1,25(OH)2D3也增加了吲哚胺2,3-双加氧酶的表达和生物学活性,介导CD4 + CD25 + T调节细胞数量的显着增加。总体而言,这些数据表明在多发性硬化过程中1,25(OH)2D3在T细胞稳态中起着重要作用,因此纠正其缺陷可能在疾病治疗中有用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号